Cognition Therapeutics, Inc. Tops Q2 EPS by 4c QA

  • Investing.com
Cognition Therapeutics, Inc. Tops Q2 EPS by 4c QA

Cognition Therapeutics, Inc. (CGTX) reported Q2 EPS of ($0.25), $0.04 better than the analyst estimate of ($0.29).

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles